HBOT for Decompression Sickness

The original and most strongly validated HBOT indication — recompression therapy for divers with DCS or arterial gas embolism.

HBOT Hub — http://localhost:3003/conditions/decompression-sickness · Printed October 11, 2026 · UHMS approved · Emergency · Gold standard

GRADE Evidence Rating

Quality: High Strong recommendation

US Navy Treatment Table 6 has decades of clinical use. RCT impractical (life-threatening emergency). Universal standard of care.

Overview

Decompression sickness and arterial gas embolism are the original and most strongly validated HBOT indications. US Navy Treatment Table 6 (60-foot-equivalent dive with oxygen breathing periods) remains the gold standard recompression protocol worldwide.

How HBOT Works

Recompression reduces bubble size by increasing ambient pressure, allowing dissolved inert gas to redistribute. Oxygen breathing eliminates nitrogen from blood (nitrogen washout) and provides tissue oxygenation to ischaemic regions. Gradual decompression allows safe elimination of the dissolved gas load without recurrence of bubbles.

Clinical Protocol

Typical protocolUS Navy Table 6 (2.8 ATA with periodic oxygen) — single acute treatment
Evidence levelStandard of care — Universal
FDA / regulatory statusPrimary FDA-approved indication

Table 6: compression to 60 fsw (2.8 ATA), oxygen breathing periods alternating with air breaks, gradual decompression over 4–5 hours total. Table 6A: extended version for severe or recurrent cases, up to 8+ hours. Additional sessions as needed for persistent or recurrent symptoms.

Cautions & Considerations

Key Research

Indexed studies

Questions to Ask Your Doctor

  1. Am I a candidate for HBOT for this condition given my medical history and current treatments?
  2. What pressure (ATA) and session count would you recommend, and why?
  3. Is treatment at this centre UHMS-accredited? What is the chamber type (monoplace or multiplace)?
  4. What is the expected response rate and typical timeline for improvement?
  5. What are the specific contraindications and side-effect risks in my case?
  6. What is the expected cost and insurance coverage status?
  7. What alternative or complementary treatments should I consider?
  8. How will we measure whether treatment is working?